Abstract:Objective To quantify the changes in blood glucose, blood lipids, blood pressure, and the intima-media thickness (IMT) of large arteries in patients with new-onset type 2 diabetes mellitus who received either intensive multifactorial treatment or conventional treatment. Methods Two-hundred and ten patients with new-onset type 2 diabetes mellitus were randomly assigned to two groups: an intensive treatment group ( n =110) and a conventional treatment group ( n =100). Fasting blood glucose (FBG), glycosylated hemoglobin A1c (HbA1c), blood pressure, blood lipids [total cholesterol (TC), triglyceride (TG), low-density lipoprotein C (LDL-C), and high-density lipoprotein C (HDL-C)], and IMTs of large arteries (carotid, iliac, and femoral arteries) were determined before and at one and two years after starting treatment. The patients in the conventional treatment group received routine diabetes management in our outpatient department. Targets were established for patients in the intensive treatment group. Their blood glucose, blood lipids, and blood pressure levels were regularly monitored and therapeutic regimens were adjusted for those whose measurements did not meet the target values until all the parameters met the established targets. Within-group and between-group differences were evaluated. Results A significantly greater percentage of patients in the intensive treatment group had LDL-C levels that reached the target value one year after starting treatment than those in the conventional treatment group (52.04% vs. 33.33%, P <0.05). No significant differences were found between groups for FBG, HbA1c, blood pressure, TG, TC, or HDL-C. The percentages of patients with TG (51.02% vs. 34.48%), TC (52.04% vs. 33.33%), and LDL-C (61.22% vs. 43.67%) who met the respective target values in the intensive treatment group were all significantly higher than the corresponding percentages in the conventional treatment group two years after starting treatment ( P <0.05). There were no significant differences in the percentages of patients with FBG, HbA1c, and blood pressure values meeting the respective targets between the groups at the two-year follow-up. One year after starting treatment, the LDL-C level, diastolic blood pressure (DBP), and the IMTs of the femoral and iliac arteries of the intensive treatment group were significantly lower compared to those of the conventional treatment group ( P <0.05), although there was no significant difference in other metabolic parameters. Two years after starting treatment, the TC, LDL-C, blood pressure [systolic blood pressure (SBP) and DBP], and the IMTs of the carotid and femoral arteries of the intensive treatment group were significantly lower than those of the conventional treatment group ( P <0.05). No significant differences in other metabolic parameters existed between the two groups two years after starting treatment. Conclusions Early comprehensive and intensive treatment of type 2 diabetes mellitus can delay or even reverse the increase in IMT of large arteries. Lowering blood pressure and blood lipid regulation in patients with type 2 diabetes mellitus have great significance in decreasing the risk of diabetes-related macrovascular lesions.

Effects of Liu wei di huang pills on the vascular endothelial function in type 2 diabetes mellitus

Liuwei Dihuang Pills (a...a(3)ae Degrees E >>"A) Enhance the Effect of Western Medicine in Treating Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

Clinical observation of "DM120 Decoction" for type 2 diabetes mellitus: A report of 30 cases

Study on clinical effect of Yiqi Yangyin and Huoxue Prescription imposed on fatty liver in type 2 diabetes mellitus

Research on Curative Effect of Liuwei Dihuang Pill Combined with Metformin on Type 2 Diabetes and Serum Apolipoprotein Level

Effect of Intensive Multifactorial Treatment on the Intima-Media Thickness of Large Arteries in Patients with New-Onset Type 2 Diabetes Mellitus

Effects Of"lingyi Capsule"on Early Diabetic Peripheral Neuropathy:A Randomized Controlled Multi-center Double-Blind Clinical Trial

The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance

Effect of “Ying Wei Fang” on Vascular Endothelial Function in Patients with Different Syndromes of Type 2 Diabetes Mellitus

A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus

Effects of oral hypoglycemic drugs on vascular endothelial function in type 2 diabetes

The Effect of Huayu Jiangzhuo Mixture on Lipid Metabolism in Type 2 Diabetes Mellitus with Improved Glycemic Control

Hypolipidemic effect of the Chinese polyherbal Huanglian Jiedu decoction in type 2 diabetic rats and its possible mechanism

Danggui Liuhuang Decoction Ameliorates Endothelial Dysfunction by Inhibiting the JAK2/STAT3 Mediated Inflammation

[Tongxinluo Improves Vascular Endothelial Function in Patients with Type 2 Diabetes].

Effect of “Yingwei Fang” on Lower Extremity Vascular Lesions in Patients with Different Syndromic Type 2 Diabetes

Effect of Jiawei Huangqi Guizhi Wuwu Decoction on vascular endothelial growth factor in patients with dia-betic peripheral neuropathy

Clinical observation on the effects of yiqi Huaju herb formula on type 2 diabetes subjects coupled with central obesity

The effects of Buyang Huanwu Decoction on hemorheological disorders and energy metabolism in rats with coronary heart disease.

Effect of Intensive Insulin Therapy on Vascular Endothelial Function in Newly Diagnosed Type 2 Diabetes Patients

Effects of Danlou Tablets on Blood Lipid and Hemorheology in Patients with Coronary Heart Disease and Hyperlipidemia